E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia

被引:21
作者
Roman, J [1 ]
Jimenez, A
Barrios, M
Castillejo, JA
Maldonado, J
Torres, A
机构
[1] Reina Sofia Hosp, Dept Haematol, Cordoba 14004, Spain
[2] Carlos Haya Hosp, Dept Haematol, Malaga, Spain
关键词
BCR-ABL; CML; Ph-chromosome; PCR;
D O I
10.1046/j.1365-2141.2001.02971.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A woman with Ph-positive chronic myeloid leukaemia (CAM) with an atypical e1a3 BCR-ABL hybrid gene is described. To our knowledge, this is the first report of this transcript type as a unique naturally occurring BCR-ABL fusion in a CML patient. This case was characterized by a low leucocyte count and a very indolent course without treatment. Because the deletion of ABL exon 2 sequences results in deletion of an essential part of the ABL SH3 domain, our case suggests that this ABL SH3 domain is not absolutely necessary for efficient induction of a myeloproliferative disease in the context of BCR-ABL/p190.
引用
收藏
页码:635 / 637
页数:3
相关论文
共 12 条
[1]   The molecular biology of chronic myeloid leukemia [J].
Deininger, MWN ;
Goldman, JM ;
Melo, JV .
BLOOD, 2000, 96 (10) :3343-3356
[2]  
Gross AW, 1999, MOL CELL BIOL, V19, P6918
[3]  
IWATA S, 1994, LEUKEMIA, V8, P1696
[4]   BCR-ABL gene variants [J].
Melo, JV .
BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02) :203-222
[5]   Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis [J].
Nieborowska-Skorska, M ;
Wasik, MA ;
Slupianek, A ;
Salomoni, P ;
Kitamura, T ;
Calabretta, B ;
Skorski, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1229-1242
[6]   Chronic myelogenous leukaemia with p185BCR/ABL expression:: characteristics and clinical significance [J].
Ravandi, F ;
Cortes, J ;
Albitar, M ;
Arlinghaus, R ;
Guo, JQ ;
Talpaz, M ;
Kantarjian, HM .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) :581-586
[7]  
SAGLIO G, 1990, BLOOD, V76, P1819
[8]   The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: Role in adhesion, invasion, and homing [J].
Skorski, T ;
Nieborowska-Skorska, M ;
Wlodarski, P ;
Wasik, M ;
Trotta, R ;
Kanakaraj, P ;
Salomoni, P ;
Antonyak, M ;
Martinez, R ;
Majewski, M ;
Wong, A ;
Perussia, B ;
Calabretta, B .
BLOOD, 1998, 91 (02) :406-418
[9]  
SOEKARMAN D, 1990, LEUKEMIA, V4, P397
[10]  
Tiribelli M, 2000, BLOOD, V95, P4019